U.S. Airway Management Market Size, Share & Forecast 2026–2032

ID: MR-11836 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Airway Management Market
  • ✓Market Size 2024: USD 1.42 billion
  • ✓Market Size 2032: USD 2.30 billion
  • ✓CAGR: 6.2%
  • ✓Market Definition: The U.S. airway management market covers devices and consumables used to secure, ventilate, and maintain a patient's airway across hospitals, ambulatory surgery centers, and emergency services. It includes laryngoscopes, supraglottic airways, endotracheal tubes, and airway kits.
  • ✓Leading Companies: Teleflex, Ambu, Verathon, Vyaire Medical, Medline Industries
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Video laryngoscopy displacing Macintosh blades: Ambu's aScope and Verathon's GlideScope are pulling emergency department intubation volume away from reusable Macintosh blades. Hospitals adopting single-use video laryngoscopes eliminate reprocessing labor and cross-contamination exposure, favoring suppliers with domestic sterile packaging.
FINDING 02
Ambulatory growth misreads consumption: Ambulatory growth does not lift airway volumes in step with case counts. Per-case consumption is falling as ASCs favor supraglottic devices over endotracheal tubes, benefiting Teleflex's LMA franchise at the expense of tube makers such as Vyaire Medical.
ANALYST RECOMMENDATION

Analyst Recommendation — Clear FDA and GPO hurdles: Entrants should complete QMSR-aligned quality audits and file 510(k) submissions by Q3 2026, ahead of Vizient and Premier portfolio reviews in 2027. Clearance timing and GPO listing decide whether a health system adds a new airway device.

Airway Management in the U.S.: Market Overview

The U.S. airway management market is the largest national pool for intubation, ventilation, and airway rescue hardware, with 2024 revenues of roughly USD 1.42 billion. It differs from the global norm because demand concentrates in hospital operating rooms, emergency departments, and an expanding ambulatory surgery network rather than in emergency medical services. Reusable and single-use products coexist, and FDA clearance gates nearly every product entering the market.

Segment structure is distinct from Europe, where public tenders dominate. In the U.S., purchasing runs through group purchasing organizations such as Vizient and Premier, which negotiate multi-year agreements bundling airway consumables with anesthesia machines from GE HealthCare and Drägerwerk. Most hospital airway spend flows through these contracts, making incumbency in GPO catalogs the decisive commercial advantage for any new entrant.

Growth Drivers Behind U.S. Airway Management

Demographics anchor demand. The Census Bureau counts roughly 58 million Americans aged 65 and older, and this cohort drives a disproportionate share of intubated surgical procedures and ICU admissions. CMS has progressively expanded the Medicare ASC covered procedures list, and its three-year phase-out of the inpatient-only list starting in 2026 shifts more orthopedic and spine cases into outpatient sites that stock airway devices.

Clinical guidance and workforce shortages add a second driver. The American Society of Anesthesiologists' difficult airway algorithm and Difficult Airway Society guidance position video laryngoscopy as first-line equipment. Anesthesia workforce shortages push facilities toward devices that reduce intubation attempts per case, supporting adoption among nurse anesthetists and emergency physicians.

Restraints and Entry Barriers in U.S. Airway Devices

FDA premarket review sets the first barrier. Most airway devices clear through 510(k) notification, yet new video laryngoscope designs frequently draw additional information requests that extend timelines well beyond the agency's 90-day review goal. The Quality Management System Regulation, effective February 2, 2026, aligns 21 CFR Part 820 with ISO 13485 and forces suppliers to revalidate design controls and supplier audits before shipping.

Hospital contracting is the second barrier. Vizient and Premier award airway catalogs on multi-year cycles, and health systems rarely add a supplier mid-term. Section 301 duties on China-origin plastics and blade components raise landed costs for disposable kits, while incumbents such as Teleflex and Ambu hold preferred pricing that new entrants struggle to match.

Opportunities for Airway Management Entrants in the U.S.

Video laryngoscopy in emergency departments offers the clearest near-term opening. Roughly 5,000 U.S. hospital emergency departments still rely heavily on reusable Macintosh blades, and conversion to disposable video devices represents an analyst-estimated USD 180 million replacement pool through 2028. Hospitals cite lower cross-contamination risk and fewer failed attempts as the decisive reasons for switching, so entrants bundling devices with GPO-compliant pricing and training can capture first-line adoption.

Ambulatory surgery centers represent the second opening. More than 5,500 Medicare-certified ASCs lack the purchasing scale of hospital systems, so they buy prepackaged airway kits through distributors and direct channels. An analyst-estimated USD 260 million addressable pool for kits and supraglottic devices across ASC procedures supports dedicated direct-sales models, particularly for orthopedic and spine centers expanding under the Medicare covered procedures list.

Market at a Glance

MetricValue
Market Size 2024USD 1.42 billion
Market Size 2032USD 2.30 billion
Growth Rate (CAGR)6.2%
Most Critical Decision FactorFDA clearance timing and GPO listing access
Largest RegionSouth Region
Competitive StructureConsolidated; top five suppliers hold the majority of hospital spend

Leading Market Participants

  • Teleflex
  • Ambu
  • Verathon
  • Vyaire Medical
  • Intersurgical
  • ICU Medical
  • Drägerwerk
  • GE HealthCare
  • Getinge
  • Medline Industries

Regulatory and Policy Environment for U.S. Airway Devices

The FDA's Center for Devices and Radiological Health regulates airway devices under the Federal Food, Drug, and Cosmetic Act, with most products cleared through 510(k) premarket notification. MDUFA V, covering fiscal years 2023 through 2027, sets review performance goals and user fees that fund review staff. The QMSR took effect February 2, 2026, and Unique Device Identification labeling under 21 CFR Part 830 applies to airway devices already on the market.

CMS governs reimbursement through the annual Hospital Outpatient Prospective Payment System rule, the Medicare Physician Fee Schedule, and the ASC payment system, each finalized in late autumn. No federal subsidy targets airway hardware directly, so Medicare payment rates act as the effective subsidy. The Joint Commission's accreditation standards and OSHA bloodborne pathogen rules shape consumable purchasing, while Section 301 tariffs on China-origin goods require duty filings at U.S. Customs and Border Protection entry.

Long-Term Outlook for U.S. Airway Management

By 2032, the U.S. airway management market is projected to reach USD 2.30 billion at a 6.2% CAGR. Video laryngoscopes and single-use kits will account for a rising share of new purchases as emergency department and ASC procedure volumes grow. Supraglottic devices will hold steady in ambulatory settings, while reusable endotracheal tubes lose share to disposables.

Consolidation will shape supplier competition. GPO contracts will shift toward fewer, larger suppliers with domestic sterile manufacturing and QMSR-compliant quality systems. Entrants that secure clearance and GPO listings before 2028 will hold the most durable positions, while import-dependent blade makers face margin pressure from tariffs and reimbursement limits.

Frequently Asked Questions

Most airway devices clear through 510(k) premarket notification, which is the fastest route for devices with established predicates. Entrants should align their quality systems with the QMSR, which took effect February 2, 2026.
Vizient and Premier negotiate multi-year airway catalogs that health systems use as their default purchasing channel. Listing on these catalogs is typically a precondition for meaningful hospital revenue.
Emergency departments transitioning from reusable Macintosh blades to disposable video laryngoscopes offer the clearest opening. Ambulatory surgery centers expanding orthopedic and spine volumes also represent a growing, less contested channel.
Section 301 duties apply to China-origin plastics, blades, and components, raising landed costs for disposable kits. Importers must file duty classifications with U.S. Customs and Border Protection at each entry.
Entrants typically need 12 to 18 months for 510(k) clearance, quality system readiness, and distributor onboarding. GPO listing usually follows in the next contract cycle, often delaying broad hospital revenue to 2027 or later.

Market Segmentation

By Product Type
  • Laryngoscopes
  • Supraglottic Airways
  • Endotracheal Tubes
  • Airway Management Kits
  • Ventilation Masks
  • Tracheostomy Tubes
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Emergency Medical Services
  • Long-Term Care Facilities
By Distribution Channel
  • Group Purchasing Organizations
  • Direct Sales
  • Distributors
  • E-commerce

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Airway Management - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Product Type Insights
4.1 Laryngoscopes
4.2 Supraglottic Airways
4.3 Endotracheal Tubes
4.4 Airway Management Kits
4.5 Others
Chapter 05 End User Insights
5.1 Hospitals
5.2 Ambulatory Surgery Centers
5.3 Emergency Medical Services
5.4 Long-Term Care Facilities
5.5 Others
Chapter 06 Distribution Channel Insights
6.1 Group Purchasing Organizations
6.2 Direct Sales
6.3 Distributors
6.4 E-commerce
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Teleflex
7.2.2 Ambu
7.2.3 Verathon
7.2.4 Vyaire Medical
7.2.5 Intersurgical
7.2.6 ICU Medical
7.2.7 Drägerwerk
7.2.8 GE HealthCare
7.2.9 Getinge
7.2.10 Medline Industries
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.